Dr Rosemary Habib
/content/dam/genesiscare/centres-and-staff/au-centres-and-staff/au-staff/au_nsw_clinician_rosemary_habib_01.png
Medical Oncologist

Dr Rosemary Habib

Dr Rosemary Habib
Rosemary
Habib

Medical Oncologist

For patients/carers

For doctors

Medical Oncologist

Locations

Bella Vista (Norwest), NSW
Bella Vista (Norwest)
Level 3, Suite 311, 8 Elizabeth MacArthur Drive, Bella Vista, NSW, 2153, Australia
-33.74420414961466, 150.95193295767038
/au/our-centres/nsw-bella-vista-norwest
NSW

Languages

Fluent

  • English

Biography

Clinical interests in head and neck cancers, thyroid cancers, sarcomas, skin cancers, and upper gastrointestinal cancers

Dr Habib is committed to providing compassionate, personalised care and works closely with patients and their families throughout all stages of treatment.

Dr Habib graduated in medicine from Australian National University and completed her medical oncology training through Westmead and Blacktown Hospitals. She completed her PhD through University of Sydney and Westmead Institute for Medical Research, focusing on biomarker discovery and CAR T-cell development.

Alongside her clinical practice, she is actively involved in both industry-sponsored and investigator-initiated clinical trials. Dr Habib continues to contribute to translational cancer research in biomarker discovery, novel immunotherapy approaches, quality assurance, and patient-reported quality of life outcomes. She has been involved in nationally competitive grant-funded research programs, including NHMRC-supported projects, and collaborates with local, national, and international research groups to improve cancer care.

Dr Habib is also passionate about medical education and mentoring and is actively involved in teaching medical students, doctors in training, and higher degree research students. She contributes to oncology education through formal teaching, research supervision, and mentorship, with a strong focus on supporting the next generation of clinician researchers. Dr Habib also serves on local and national clinical, research, and advisory committees focused on improving cancer outcomes and research quality.